| | Editorials Journal Impact Factors for 1999 J. BRITTON and A. KNOX Thorax. 2000 September; 55(9): 725. doi: 10.1136/thorax.55.9.725.PMCID: PMC1745854 Malignant mesothelioma: predictors of prognosis and
clinical trials J STEELE and R RUDD Thorax. 2000 September; 55(9): 725–726. doi: 10.1136/thorax.55.9.725a.PMCID: PMC1745858 Hypertension in patients with sleep apnoea, a combined
effect? E FLETCHER Thorax. 2000 September; 55(9): 726–728. doi: 10.1136/thorax.55.9.726.PMCID: PMC1745856 Smoking, lung function, and mortality N ANTHONISEN Thorax. 2000 September; 55(9): 729–730. doi: 10.1136/thorax.55.9.729.PMCID: PMC1745844 Original Articles Prognostic factors for malignant mesothelioma in 142 patients:
validation of CALGB and EORTC prognostic scoring systems J Edwards, K Abrams, J Leverment, T Spyt, D Waller, and K O'Byrne Thorax. 2000 September; 55(9): 731–735. doi: 10.1136/thorax.55.9.731.PMCID: PMC1745842 Case-control study of 24 hour ambulatory blood pressure in
patients with obstructive sleep apnoea and normal matched control
subjects C. Davies, J. Crosby, R. Mullins, C. Barbour, R. Davies, and J. Stradling Thorax. 2000 September; 55(9): 736–740. doi: 10.1136/thorax.55.9.736.PMCID: PMC1745863 Comparison of two in-laboratory titration methods to determine
effective pressure levels in patients with obstructive sleep apnoea M Bureau and F Series Thorax. 2000 September; 55(9): 741–745. doi: 10.1136/thorax.55.9.741.PMCID: PMC1745846 Pulmonary function, smoking cessation and 30 year mortality in
middle aged Finnish men M. Pelkonen, H. Tukiainen, M. Tervahauta, I. Notkola, S. Kivela, Y. Salorinne, and A. Nissinen Thorax. 2000 September; 55(9): 746–750. doi: 10.1136/thorax.55.9.746.PMCID: PMC1745841 Epidemiology of familial sarcoidosis in the UK D McGrath, Z Daniil, P Foley, J L du Bois, P Lympany, P Cullinan, and R M du Bois Thorax. 2000 September; 55(9): 751–754. doi: 10.1136/thorax.55.9.751.PMCID: PMC1745852 Expression of thioredoxin in granulomas of sarcoidosis: possible
role in the development of T lymphocyte activation T. Koura, Y. Gon, S. Hashimoto, A. Azuma, S. Kudoh, Y. Fukuda, I. Sugawara, J. Yodoi, and T. Horie Thorax. 2000 September; 55(9): 755–761. doi: 10.1136/thorax.55.9.755.PMCID: PMC1745843 Asthma exacerbations during long term β agonist use: influence
of β2 adrenoceptor polymorphism D Taylor, J. Drazen, G Herbison, C. Yandava, R. Hancox, and G Town Thorax. 2000 September; 55(9): 762–767. doi: 10.1136/thorax.55.9.762.PMCID: PMC1745862 Induced sputum in children: feasibility, repeatability, and
relation of findings to asthma severity N. Wilson, P. Bridge, A. Spanevello, and M. Silverman Thorax. 2000 September; 55(9): 768–774. doi: 10.1136/thorax.55.9.768.PMCID: PMC1745860 Diet and childhood asthma in a society in transition: a study in
urban and rural Saudi Arabia N. Hijazi, B. Abalkhail, and A. Seaton Thorax. 2000 September; 55(9): 775–779. doi: 10.1136/thorax.55.9.775.PMCID: PMC1745853 Salmeterol in paediatric asthma C. Byrnes, S. Shrewsbury, P. Barnes, and A. Bush Thorax. 2000 September; 55(9): 780–784. doi: 10.1136/thorax.55.9.780.PMCID: PMC1745864 Which spirometric indices best predict subsequent death from
chronic obstructive pulmonary disease? M. Thomason and D. Strachan Thorax. 2000 September; 55(9): 785–788. doi: 10.1136/thorax.55.9.785.PMCID: PMC1745857 Recent trends in physician diagnosed COPD in women and men in the
UK J. Soriano, W. Maier, P. Egger, G. Visick, B. Thakrar, J. Sykes, and N. Pride Thorax. 2000 September; 55(9): 789–794. doi: 10.1136/thorax.55.9.789.PMCID: PMC1745847 Increased sputum amino acid concentrations and auxotrophy of
Pseudomonas aeruginosa in severe cystic
fibrosis lung disease S. Thomas, A. Ray, M. Hodson, and T. Pitt Thorax. 2000 September; 55(9): 795–797. doi: 10.1136/thorax.55.9.795.PMCID: PMC1745865 Osteoporosis and osteopenia in adults and adolescents with cystic
fibrosis: prevalence and associated factors S Conway, A Morton, B Oldroyd, J Truscott, H White, A Smith, and I Haigh Thorax. 2000 September; 55(9): 798–804. doi: 10.1136/thorax.55.9.798.PMCID: PMC1745849 Case Report Churg-Strauss syndrome associated with montelukast therapy J Tuggey and H Hosker Thorax. 2000 September; 55(9): 805–806. doi: 10.1136/thorax.55.9.805.PMCID: PMC1745850 Letters to the Editor PEF versus FEV1 I. GREGG, D POSTMA, T. W VAN DER MARK, and H THIADENS Thorax. 2000 September; 55(9): 807. doi: 10.1136/thorax.55.9.807.PMCID: PMC1745855 Differentiation between mitral stenosis and coexisting PPH T. CHENG, D LANGLEBEN, and R SCHLESINGER Thorax. 2000 September; 55(9): 807. doi: 10.1136/thorax.55.9.807a.PMCID: PMC1745866 Caring for indigenous Australian children with asthma A CHANG, C SHANNON, I MASTERS, and M. PARTRIDGE Thorax. 2000 September; 55(9): 807. doi: 10.1136/thorax.55.9.807b.PMCID: PMC1745840 Intravenous montelukast in acute asthma: expensive
aminophylline? O. DEMPSEY, B. LIPWORTH, and T. REISS Thorax. 2000 September; 55(9): 807. doi: 10.1136/thorax.55.9.807c.PMCID: PMC1745845 TB guidelines J COOKSON, M MORGAN, J WALES, I PAVORD, A WARDLAW, P BRADDING, P. ORMEROD, and I. CAMPBELL Thorax. 2000 September; 55(9): 807. doi: 10.1136/thorax.55.9.807d.PMCID: PMC1745851 Book Reviews Hunter's Diseases of Occupations. Thorax. 2000 September; 55(9): 810. doi: 10.1136/thorax.55.9.810.PMCID: PMC1745859 Cystic Fibrosis Medical Care. Thorax. 2000 September; 55(9): 810. doi: 10.1136/thorax.55.9.810a.PMCID: PMC1745861 Journal Matter Original table of contents page |